Akinsanya Karen 4
4 · Schrodinger, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Akinsanya Karen
President of R&D, Therapeutics
Transactions
- Award
Stock Option (right to buy)
2024-03-04+120,000→ 120,000 totalExercise: $25.24Exp: 2034-03-04→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.